Wei-Hsien Liu

Inner Mongolia Yili Industrial Group (China)

Health Outcomes Studied

• Improved Gut Microbiota Composition
• Reduced Flatulence

Papers (4)

• 2023
  Bifidobacterium animalis subsp. lactis BL-99 ameliorates colitis-related lung injury in mice by modulating short-chain fatty acid production and inflammatory monocytes/macrophages.10.1039/d2fo03374g
• 2022
  <i>In vitro</i> Study of <i>Bifidobacterium lactis</i> BL-99 With Fructooligosaccharide Synbiotics Effected on the Intestinal Microbiota.10.3389/fnut.2022.890316
• 2022
  Bifidobacterium lactis BL-99 protects mice with osteoporosis caused by colitis via gut inflammation and gut microbiota regulation.10.1039/d1fo02218k
• 2021
  Safety Evaluation of Bifidobacterium lactis BL-99 and Lacticaseibacillus paracasei K56 and ET-22 in vitro and in vivo10.3389/fmicb.2021.686541